Search Results for 'Oncol Clin'

Oncol Clin published presentations and documents on DocSlides.

Case ReportJ Gynecol Oncol Vol 19 No 2145149 June 2008DOI10380

Case ReportJ Gynecol Oncol Vol 19 No 2145149 June 2008DOI10380

by walsh

A case of inguinal lymph node squamous cell carcin...

Is Sentinel Lymph Node Biopsy Enough for Axillary

Is Sentinel Lymph Node Biopsy Enough for Axillary

by tatyana-admore

Macrometastasis. ? . Merdan . Fayda. , MD, . Asso...

Is Sentinel Lymph Node Biopsy Enough for Axillary

Is Sentinel Lymph Node Biopsy Enough for Axillary

by conchita-marotz

Macrometastasis. ? . Merdan . Fayda. , MD, . Asso...

GIスライドデッキ2018

by crandone

以下の会議で発表された特定の抄録�...

Colorectal Cancer in Older

Colorectal Cancer in Older

by stingraycartier

Patients. Key Issues. Etienne GC . Brain. , MD . P...

METASTASES HEPATIQUES CRC :point de vue de l’ oncologue

METASTASES HEPATIQUES CRC :point de vue de l’ oncologue

by jiggyhuman

F DESSEIGNE TANGER 27 04 2018. Phase III First-Lin...

ContentslistsavailableatCriticalReviewsinOncologyHematologyjournalhom

ContentslistsavailableatCriticalReviewsinOncologyHematologyjournalhom

by isla

CervicalcancerpatternsofcareinItalyAradiationoncol...

Cryotherapy for the Treatment of

Cryotherapy for the Treatment of

by amelia

Prostate Cancer . C. Ryan Barnes, MD. Virginia Uro...

EGFR Mutation in Lung Adenocarcinoma (ADC)

EGFR Mutation in Lung Adenocarcinoma (ADC)

by QuietConfidence

Ana Rima. Lung Cancer: Incidence and Mortality. Ne...

Diffuse Intrinsic Pontine Glioma

Diffuse Intrinsic Pontine Glioma

by natalie

ARRO Case: Nicholas DeNunzio, MD, PhD (PGY - 3) F...

Prediction and Possible

Prediction and Possible

by carla

Reduction. of . Toxicity. of . Chemotherapy. in...

Managing Breast Cancer in the Genomic Era

Managing Breast Cancer in the Genomic Era

by alida-meadow

Leisha. A. . Emens. , M.D., . Ph.D. Associate Pr...

by luanne-stotts

Brada. . Torino. . 6 March 2015. Perspectives...

Please note, these are the actual video-recorded proceeding

Please note, these are the actual video-recorded proceeding

by lindy-dunigan

Moderator. Neil Love, MD. Jessica Mitchell, RN, C...

Towards a Complete Solution for Cost/Effectiveness in Oncol

Towards a Complete Solution for Cost/Effectiveness in Oncol

by faustina-dinatale

Gerhardt Pohl. Eli Lilly and Company. Objective. ...

Toxicities of Radiation Therapy in Cancer

Toxicities of Radiation Therapy in Cancer

by natalia-silvester

Bradley . Burton, . PharmD. , BCOP, . CACP. Septe...

17th Annual International Congress

17th Annual International Congress

by conchita-marotz

on . Hematologic Malignancies. ®. : . Focus . on...

by alida-meadow

treatments. in WT . pts. : . which. . opportuni...

by pamella-moone

E. xtragonadal. Germ . C. ell . T. umors: Focus ...

Thomas E. Keane

Thomas E. Keane

by danika-pritchard

Medical University of South Carolina . Charleston...

T o Starve Cancer to Death!

T o Starve Cancer to Death!

by tatiana-dople

——. The Anti-angiogenesis . E. ffects in the ...

Where we are with targeted

Where we are with targeted

by stefany-barnette

therapies . for . cholangiocarcinoma. Professor J...

Antiangiogenic Agents in Advanced NSCLC

Antiangiogenic Agents in Advanced NSCLC

by ellena-manuel

Jared Weiss, MD . Assistant . Professor of Medici...

Supplemental Figure 1. Mutation frequencies in adenocarcinoma of the lung

Supplemental Figure 1. Mutation frequencies in adenocarcinoma of the lung

by giovanna-bartolotta

Data source: . Wang R, Pan Y, Li C, et al. Analys...

James L. Gulley M.D. , Ph.D.,

James L. Gulley M.D. , Ph.D.,

by tatyana-admore

F.A.C.P. .. Head, Immunotherapy Section. Chief, G...

EGFR-Mutated Advanced NSCLC

EGFR-Mutated Advanced NSCLC

by sherrill-nordquist

The Coming Paradigm Shift. Faculty. Suresh S. Ram...

Alexander Olinger , PharmD

Alexander Olinger , PharmD

by mitsue-stanley

PGY-2 Oncology Pharmacy Resident. Pharmacy Grand...

Sipuleucel -T Survival Benefit

Sipuleucel -T Survival Benefit

by calandra-battersby

Sipuleucel. -T was approved based on HR of 0.775 ...

Cancer Unknown Primary Sarah W. Gordon, DO

Cancer Unknown Primary Sarah W. Gordon, DO

by olivia-moreira

Assistant Professor. Virginia Commonwealth Univer...

ADVANCES IN THERAPY FOR SARCOMA AND GIST

ADVANCES IN THERAPY FOR SARCOMA AND GIST

by ellena-manuel

Angela . Cioffi. , MD. Sarcoma Research Program c...

It takes more than milk to improve bone health!!

It takes more than milk to improve bone health!!

by aaron

Lawrence Drudge-Coates. Urological Oncology Clini...

CDK 4/6 Inhibitors in Breast Cancer Expert Perspectives on New Data

CDK 4/6 Inhibitors in Breast Cancer Expert Perspectives on New Data

by min-jolicoeur

CDK 4/6 Inhibitors in Breast Cance...

Ezra W Cohen University of California, San Diego

Ezra W Cohen University of California, San Diego

by natalia-silvester

Ezra W Cohen University of California, San Diego...

The Role of Antiangiogenic Agents

The Role of Antiangiogenic Agents

by luanne-stotts

The Role of Antiangiogenic Agents in the Changin...

DRA. CRUZ MORALES GEORGINA R1GO

DRA. CRUZ MORALES GEORGINA R1GO

by bubbleba

TUMORES DEL ESTROMA GONADAL. Temario. Introducció...

The Nurse View: Practice

The Nurse View: Practice

by conterc

Pearls in . the Use . of . Immune . Checkpoint Inh...

by warlikebikers

cancer. , right vs . left. : . how. to take . it....

Anticoagulant Options for the Management of Acute Cancer-Associated Thrombosis

Anticoagulant Options for the Management of Acute Cancer-Associated Thrombosis

by collectmcdonalds

Presented by. Faculty/Presenter Disclosure. Facult...

Immuno-Oncology Adverse Event Management

Immuno-Oncology Adverse Event Management

by everly

Why is it different? . Why is it important?. Dr Av...

Screening, Geriatric Assessment and Interventions

Screening, Geriatric Assessment and Interventions

by layla

Pierre . Soubeyran. and Siri Rostoft. Disclosure....